Infliximab produces a sustained and significant improvement in psoriasis over 50 weeks of continuous therapy (Abstract O-10). The 85th BAD Annual Meeting 5-8th July 2005, Glasgow, UK

Categoría Estudio primario
RevistaBritish journal of dermatology
Año 2005
Este artículo no tiene resumen
Epistemonikos ID: 1dccbaa3721a485855be55f25270f64ca300c59a
First added on: Aug 03, 2015